Related Experiment Video
Updated: May 25, 2026
An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers
Published on: December 1, 2017
2009 H1N1 vaccination by pregnant women during the 2009-10 H1N1 influenza pandemic
Yosef Dlugacz1, Adiel Fleischer, Maria Torroella Carney
1Krasnoff Quality Management Institute, North Shore-LIJ Health System, Hempstead, NY, USA.
Objective:
Pregnant women were identified at greater risk and given priority for 2009 H1N1 vaccination during the 2009 through 2010 H1N1 pandemic. We identified factors associated with acceptance or refusal of 2009 H1N1 vaccination during pregnancy.
Study Design:
We conducted an in-person survey of postpartum women on the labor and delivery service from June 17 through Aug. 13, 2010, at 4 New York hospitals.
Results:
Of 1325 survey respondents, 34.2% received 2009 H1N1 vaccination during pregnancy. A provider recommendation was most strongly associated with vaccine acceptance (odds ratio [OR], 19.4; 95% confidence interval [CI], 12.7-31.1). Also more likely to take vaccine were women indicating the vaccine was safe for the fetus (OR, 12.4; 95% CI, 8.3-19.0) and those who previously took seasonal flu vaccination (OR, 7.9; 95% CI, 5.8-10.7). Race, education, income, and age were less important in accepting vaccine.
Conclusion:
Greater emphasis on vaccine safety and provider recommendation is needed to increase the number of women vaccinated during pregnancy.
Related Concept Videos
01:51Vaccinations
01:27Influenza
01:22Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...